Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1953 Nov;32(11):1117–1120. doi: 10.1172/JCI102835

THE EFFECTS OF ANTIMICROBIAL AGENTS UPON CHOLINE DEGRADATION IN THE INTESTINAL TRACT

J De La Huerga 1,2,3, Paul György 1,2,3, Sheldon Waldstein 1,2,3, Ricardo Katz 1,2,3, Hans Popper 1,2,3
PMCID: PMC438450  PMID: 13108974

Full text

PDF
1117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAXTER J. H., CAMPBELL H. Effects of aureomycin on renal lesions, liver lipid, and tissue choline in choline deficiency. Proc Soc Exp Biol Med. 1952 Jul;80(3):415–419. doi: 10.3181/00379727-80-19641. [DOI] [PubMed] [Google Scholar]
  2. DE LA HUERGA J., POPPER H. Factors influencing choline absorption in the intestinal tract. J Clin Invest. 1952 Jun;31(6):598–603. doi: 10.1172/JCI102646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DUCCI H., KATZ R. Cortisone, ACTH and antibiotics in fulminant hepatitis. Gastroenterology. 1952 Jul;21(3):357–374. [PubMed] [Google Scholar]
  4. FARQUHAR J. D., STOKES J., Jr, WHITLOCK C. M., Jr, BLUEMLE L. W., Jr, GAMBESCIA J. M. Studies on the use of aureomycin in hepatic disease. III. A note on aureomycin therapy in hepatic coma. Am J Med Sci. 1950 Aug;220(2):166–172. doi: 10.1097/00000441-195008000-00007. [DOI] [PubMed] [Google Scholar]
  5. GYORGY P., STOKES J., Jr, GOLDBLATT H. Antimicrobial agents in the prevention of experimental dietary injury of the liver. Trans Assoc Am Physicians. 1951;64:289–296. [PubMed] [Google Scholar]
  6. GYORGY P., STOKES J., Jr, GOLDBLATT H., POPPER H. Antimicrobial agents in the prevention of dietary hepatic injury (necrosis, cirrhosis) in rats. J Exp Med. 1951 Jun;93(6):513–522. doi: 10.1084/jem.93.6.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. ZASLOW J., HEWLETT T. H., GOLDSMITH R. The excretion and concentration of aureomycin in the abnormal human biliary tract. Gastroenterology. 1950 Oct;16(2):479–483. [PubMed] [Google Scholar]
  8. ZASLOW J., HEWLETT T. H., LORRY R. W. The excretion and concentration of aureomycin in the abnormal human biliary tract. Gastroenterology. 1950 Oct;16(2):475–478. [PubMed] [Google Scholar]
  9. de la HUERGA J., POPPER H. Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases. J Clin Invest. 1951 May;30(5):463–470. doi: 10.1172/JCI102463. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES